Kailera Therapeutics, Inc. (KLRA) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Kailera Therapeutics, Inc. (KLRA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.84B, listed on NASDAQ, employing roughly 145 people, carrying a beta of 0.00 to the broader market. Kailera Therapeutics is a clinical-stage biopharmaceutical company developing a diverse pipeline of next-generation therapies designed to treat obesity and related conditions. Led by Ronald C. Renaud Jr., public since 2026-04-17.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for KLRA as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →